Oskar A. Haas

844 total citations
27 papers, 617 citations indexed

About

Oskar A. Haas is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Oskar A. Haas has authored 27 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 9 papers in Molecular Biology and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Oskar A. Haas's work include Acute Myeloid Leukemia Research (15 papers), Acute Lymphoblastic Leukemia research (8 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Oskar A. Haas is often cited by papers focused on Acute Myeloid Leukemia Research (15 papers), Acute Lymphoblastic Leukemia research (8 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Oskar A. Haas collaborates with scholars based in Austria, United States and Germany. Oskar A. Haas's co-authors include Andreas Weinhäusel, Klaus Lechner, Peter Bettelheim, Werner Linkesch, Walter Knapp, Jochen Harbott, Christian Urban, D. Lutz, Elisabeth Paietta and E Neumann and has published in prestigious journals such as Blood, Cancer and International Journal of Cancer.

In The Last Decade

Oskar A. Haas

27 papers receiving 603 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oskar A. Haas Austria 15 416 235 230 125 83 27 617
Klasien B.J. Gerssen‐Schoorl Netherlands 8 383 0.9× 188 0.8× 184 0.8× 122 1.0× 93 1.1× 9 616
S. Patil United States 9 493 1.2× 193 0.8× 321 1.4× 137 1.1× 31 0.4× 15 724
Andrea Teigler‐Schlegel Germany 15 529 1.3× 393 1.7× 295 1.3× 78 0.6× 152 1.8× 27 753
OA Haas Austria 15 656 1.6× 369 1.6× 407 1.8× 221 1.8× 76 0.9× 18 904
Michel Zwaan Netherlands 8 335 0.8× 263 1.1× 320 1.4× 78 0.6× 67 0.8× 19 715
SP Hunger United States 14 636 1.5× 491 2.1× 491 2.1× 127 1.0× 94 1.1× 21 986
Jürgen Groet United Kingdom 12 243 0.6× 215 0.9× 213 0.9× 63 0.5× 46 0.6× 15 502
Mary Martineau United Kingdom 13 622 1.5× 722 3.1× 166 0.7× 97 0.8× 227 2.7× 17 949
N Bown United Kingdom 10 219 0.5× 122 0.5× 275 1.2× 88 0.7× 23 0.3× 18 558
Barbara Adler‐Brecher United States 7 197 0.5× 111 0.5× 462 2.0× 47 0.4× 67 0.8× 9 677

Countries citing papers authored by Oskar A. Haas

Since Specialization
Citations

This map shows the geographic impact of Oskar A. Haas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oskar A. Haas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oskar A. Haas more than expected).

Fields of papers citing papers by Oskar A. Haas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oskar A. Haas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oskar A. Haas. The network helps show where Oskar A. Haas may publish in the future.

Co-authorship network of co-authors of Oskar A. Haas

This figure shows the co-authorship network connecting the top 25 collaborators of Oskar A. Haas. A scholar is included among the top collaborators of Oskar A. Haas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oskar A. Haas. Oskar A. Haas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Boehm, Alexandra, Wolfgang R. Sperr, Gerda Leitner, et al.. (2008). Comorbidity predicts survival in myelodysplastic syndromes or secondary acute myeloid leukaemia after allogeneic stem cell transplantation. European Journal of Clinical Investigation. 38(12). 945–952. 37 indexed citations
3.
Beverloo, H. Berna, A. Veerman, Bruce M. Camitta, et al.. (2004). In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype. Leukemia. 18(3). 521–529. 55 indexed citations
4.
Schmidt, Helmut H., Sabine Strehl, Daniela Thaler, et al.. (2004). RT-PCR and FISH analysis of acute myeloid leukemia with t(8;16)(p11;p13) and chimeric MOZ and CBP transcripts: breakpoint cluster region and clinical implications. Leukemia. 18(6). 1115–1121. 30 indexed citations
5.
Gadner, Helmut, Oskar A. Haas, Giuseppe Masera, C-H Pui, & Martin Schrappe. (2003). ‘Ponte di Legno’ Working Group – Report on the Fifth International Childhood Acute Lymphoblastic Leukemia Workshop: Vienna, Austria, 29 April – 1 May 2002. Leukemia. 17(4). 798–803. 10 indexed citations
6.
Parolini, Ornella, Birgit Kagerbauer, Peter F. Ambros, et al.. (2002). Analysis of SH2D1A mutations in patients with severe Epstein-Barr virus infections, Burkitt's lymphoma, and Hodgkin's lymphoma. Annals of Hematology. 81(8). 441–447. 12 indexed citations
7.
Weinhäusel, Andreas & Oskar A. Haas. (2001). Evaluation of the fragile X (FRAXA) syndrome with methylation-sensitive PCR. Human Genetics. 108(6). 450–458. 31 indexed citations
8.
Borkhardt, Arndt, Andrea Teigler‐Schlegel, Uta Fuchs, et al.. (2001). An ins(X;11)(q24;q23) fuses the MLL and the Septin 6/KIAA0128 gene in an infant with AML‐M2. Genes Chromosomes and Cancer. 32(1). 82–88. 43 indexed citations
9.
Exner, Markus, et al.. (2000). The ?typical? immunophenotype of acute promyelocytic leukemia (APL-M3): Does it prove true for the M3-variant?. Cytometry. 42(2). 106–109. 27 indexed citations
10.
Li, Xuri, et al.. (1998). Promoter-specific methylation and expression alterations of igf2 and h19 are involved in human hepatoblastoma. International Journal of Cancer. 75(2). 176–180. 19 indexed citations
11.
Mitterbauer, Margit, Gerlinde Mitterbauer, Oskar A. Haas, et al.. (1995). Kinetics of minimal residual disease during induction/consolidation therapy in standard-risk adult B-lineage acute lymphoblastic leukemia. Annals of Hematology. 71(4). 155–160. 1 indexed citations
12.
Schmidt, Helmut H., et al.. (1995). Hodgkin's disease developing after spontaneous remission of chronic lymphocytic leukemia. Annals of Hematology. 71(5). 247–252. 2 indexed citations
13.
Haas, Oskar A., et al.. (1993). Immunophenotype of Hematologic Neoplasms with a Translocation t(8;21). Recent results in cancer research. 131. 361–368. 2 indexed citations
14.
Marosi, Christine, Manfred Muhm, Hendrati Pirc‐Danoewinata, et al.. (1993). Tetrasomy 8 in acute monoblastic leukemia (AML-M5a) with myelosarcomatosis of the skin. Cancer Genetics and Cytogenetics. 71(1). 50–54. 27 indexed citations
15.
Marosi, C., Ursula Köller, Ilse Schwarzinger, et al.. (1992). Prognostic impact of karyotype and immunologic phenotype in 125 adult patients with de novo AML. Cancer Genetics and Cytogenetics. 61(1). 14–25. 55 indexed citations
16.
Slavc, Irene, C. Urban, J. Ritter, et al.. (1992). Paraparesis secondary to a spinal mass as the presenting feature of erythroleukaemia in a 10-month-old child. European Journal of Pediatrics. 151(5). 332–335. 3 indexed citations
17.
Slavc, Irene, Christian Urban, Oskar A. Haas, Peter M. Kroisel, & Ursula Köller. (1991). Acute megakaryocytic leukemia in children clinical, immunologic, and cytogenetic findings in two patients. Cancer. 68(10). 2266–2272. 23 indexed citations
18.
Grois, Nicole, et al.. (1989). Is trisomy 22 in acute myeloid leukemia a primary abnormality or only a secondary change associated with inversion 16?. Cancer Genetics and Cytogenetics. 43(1). 119–129. 18 indexed citations
19.
Zielinski, C., et al.. (1988). Shift in phenotype of acute T-lymphocytic leukemia to eosinophilic leukemia: a case report.. PubMed. 100(10). 331–6. 1 indexed citations
20.
Zoubek, A., Oskar A. Haas, Ruth Ladenstein, Helmut Gadner, & T Radaszkiewicz. (1986). Hemophagocytic Syndrome with Restricted Organ Involvement: Excessive Hemosiderosis and Fibrosis of the Spleen. Pediatric Hematology and Oncology. 3(2). 135–142. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Klasien B.J. Gerssen‐Schoorl Breakdown of academic impact, for papers by S. Patil Breakdown of academic impact, for papers by Andrea Teigler‐Schlegel Breakdown of academic impact, for papers by OA Haas Breakdown of academic impact, for papers by Michel Zwaan Breakdown of academic impact, for papers by SP Hunger Breakdown of academic impact, for papers by Jürgen Groet Breakdown of academic impact, for papers by Mary Martineau Breakdown of academic impact, for papers by N Bown Breakdown of academic impact, for papers by Barbara Adler‐Brecher
Rankless by CCL
2026